BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gronowitz E, Pitkänen S, Kjellmer I, Heikinheimo M, Strandvik B. Association between serum oncofetal antigens CA 19-9 and CA 125 and clinical status in patients with cystic fibrosis. Acta Paediatr. 2003;92:1267-1271. [PMID: 14696845 DOI: 10.1111/j.1651-2227.2003.tb00495.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Barouchos N, Papazafiropoulou A, Iacovidou N, Vrachnis N, Barouchos N, Armeniakou E, Dionyssopoulou V, Mathioudakis AG, Christopoulou E, Koltsida S, Bassiakou E. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations. Scand J Clin Lab Invest 2015;75:126-32. [PMID: 25598350 DOI: 10.3109/00365513.2014.992944] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
2 Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, Robberecht E, Stern M, Strandvik B, Wolfe S. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35:557-577. [PMID: 27068495 DOI: 10.1016/j.clnu.2016.03.004] [Cited by in Crossref: 207] [Cited by in F6Publishing: 156] [Article Influence: 34.5] [Reference Citation Analysis]
3 Piché A. Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker. World J Obstet Gynecol 2016; 5(1): 39-49 [DOI: 10.5317/wjog.v5.i1.39] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Nagy B Jr, Nagy B, Fila L, Clarke LA, Gönczy F, Bede O, Nagy D, Újhelyi R, Szabó Á, Anghelyi A, Major M, Bene Z, Fejes Z, Antal-Szalmás P, Bhattoa HP, Balla G, Kappelmayer J, Amaral MD, Macek M Jr, Balogh I. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis. Chest 2016;150:661-72. [PMID: 27105680 DOI: 10.1016/j.chest.2016.04.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
5 Denis JA, Mazzola A, Nguyen G, Lacorte JM, Brochet C, Larsen AK, Conti F. Transient increase of CA 19-9 serum concentrations in a liver transplant recipient with cystic fibrosis and hepatic abscess: a case report and brief literature review.Clin Biochem. 2019;64:53-56. [PMID: 30342018 DOI: 10.1016/j.clinbiochem.2018.10.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Oermann CM, Al-Salmi Q, Seilheimer DK, Finegold M, Tatevian N. Mucinous cystadenocarcinoma of the pancreas in an adolescent with cystic fibrosis.Pediatr Dev Pathol. 2005;8:391-396. [PMID: 16010483 DOI: 10.1007/s10024-005-4114-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
7 Zhang M, Zhang Y, Fu J, Zhang L. Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Elsevier; 2019. pp. 241-52. [DOI: 10.1016/bs.pmbts.2018.12.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Alexander CL, Urbanski SJ, Hilsden R, Rabin H, MacNaughton WK, Beck PL. The risk of gastrointestinal malignancies in cystic fibrosis: case report of a patient with a near obstructing villous adenoma found on colon cancer screening and Barrett's esophagus.J Cyst Fibros. 2008;7:1-6. [PMID: 17766191 DOI: 10.1016/j.jcf.2007.07.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]